This content is machine translated Bronchial asthma Practice-oriented update on a common disease Bronchial asthma is a common disease. The initial diagnosis is made by the family physician. For stable, controlled asthma, monitor lung function every one to two years.
View Post 6 min This content is machine translated Treatment of flu-like infections Inhale with essential oils Inhalations with essential oils or essences represent an old form of therapy, which in Western countries are used mainly for the treatment of flu-like infections. Interestingly, there are almost no…
View Post 7 min This content is machine translated Pulmonary rehabilitation The way to an active life Pulmonary rehabilitation is a cornerstone in the treatment of advanced chronic lung disease. It improves performance, quality of life and risk of hospitalization. Hardly any drug shows a comparably positive…
View Post 8 min This content is machine translated Interstitial lung disease ILD are rare, but must not be forgotten Interstitial lung disease is relatively uncommon in family practice. Nevertheless, it should be considered in cases of chronic dyspnea, dry cough, and fine-bubbled rales. Early and correct diagnosis is critical.…
View Post 5 min This content is machine translated Zurich COPD Day 2017 The correct inhalation technique is crucial Adequate use of inhaled medications in COPD is important. Each patient must find the product that is right for them. This reduces the still frequent errors during inhalation.
View Post 7 min This content is machine translated Cystic fibrosis A “childhood disease” has grown up Improvements in disease management increase the quality of life and life expectancy of patients with cystic fibrosis. Newborn screening, introduced in 2011, enables early diagnosis. However, the disease should also…
View Post 6 min This content is machine translated ESMO 2017 in Madrid Blocking the “escape route” for the tumor Upsets in first-line therapy of non-small cell EGFR-mutated lung cancer are imminent. With the FLAURA trial, osimertinib is confidently presenting itself for the first time as a treatment option for…
View Post 11 min This content is machine translated Curatively treated NSCLC Update on aftercare Approximately half of patients with newly diagnosed NSCLC can be treated with curative therapy. In the first three years thereafter, the likelihood of relapse is greatest. There is no good…
View Post 9 min This content is machine translated Differential diagnosis of dyspnea Principles of clarification in the outpatient setting Dyspnea is a common symptom with a broad differential diagnosis. Further instrumental examinations should be planned based on the history and clinic. Knowledge of the exact mechanism is the basis…
View Post 4 min This content is machine translated PD1/PD-L1 in second-line therapy for metastatic NSCLC. The agony of choice The treatment of bronchial carcinoma is greatly changed by immunotherapy. Current developments will lead to an adjustment of our therapy algorithms in the coming months.
View Post 5 min This content is machine translated European Lung Cancer Conference in Geneva Therapy of small cell lung tumors – focus on neutropenia Update on the use of granulocyte colony stimulating factor (G-CSF) in concurrent chemoradiotherapy. Administration in patients with small cell lung cancer may be safer than previously thought.
